proxyvotesnow.com

Home › Upcoming votes › 20/20 Biolabs, Inc.

20/20 Biolabs, Inc. Special Meeting December 9, 2026: What's on the Ballot

Merger or special meeting

Read the proxy statement on EDGAR

What’s on the ballot

Ballot read from the proxy statement and checked. As listed in 20/20 Biolabs, Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.

#ItemProposed byBoard recommends
1 Approval Proposal 2 requires Board For
2 To approve the adjournment of the Special Meeting to a later
Adjournment
Board For

Filings for this meeting

About this page

The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.